1,128
Views
7
CrossRef citations to date
0
Altmetric
Clinical Study

Clinical and pathologic characteristics of pauci-immune anti-myeloperoxidase antibody associated glomerulonephritis with nephrotic range proteinuria

, , , , &
Pages 554-560 | Received 10 Jan 2018, Accepted 07 Jun 2018, Published online: 03 Oct 2018

References

  • Kallenberg CG. Key advances in the clinical approach to ANCA-associated vasculitis. Nat Rev Rheumatol. 2014;10:484–493.
  • Kallenberg CG, Stegeman CA, Abdulahad WH, et al. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention. Am J Kidney Dis. 2013;62:1176–1187.
  • Sinico RA, Di Toma L, Radice A. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev. 2013;12:477–482.
  • Khalighi MA, Wang S, Henriksen KJ, et al. Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients. Pediatr Nephrol. 2015;30:953–959.
  • Berden AE, Ferrario F, Hagen EC, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21:1628–1636.
  • Praga M, Borstein B, Andres A, et al. Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition. Am J Kidney Dis. 1991;17:330–338.
  • Chen M, Zhou FD, Zhao MH, et al. Normoalbuminaemia is associated with IgA nephropathy in primary glomerulopathy with nephrotic-range proteinuria in Chinese patients. Nephrol Dial Transplant. 2011;26:1247–1252.
  • Ma TT, Huang YM, Wang C, et al. Coagulation and fibrinolysis index profile in patients with ANCA-associated vasculitis. PLoS One. 2014;9:e97843
  • Yu F, Chen M, Wang SX, et al. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney. Nephrology (Carlton). 2007;12:74–80.
  • Haas M, Eustace JA. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int. 2004;65:2145–2152.
  • Singh NP, Gulati S, Garg V, et al. Nephrotic range proteinuria in c-ANCA-positive crescentic glomerulonephritis with linear immune deposits. Indian J Nephrol. 2008;18:169–172.
  • Shimada M, Fujita T, Nakamura N, et al. A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy. BMC Nephrol. 2013;14:73.
  • Huang X, Wang Y, Xie L, et al. IgA nephropathy with anti-neutrophil cytoplasmic antibody seropositivity. Clin Nephrol. 2015;84:156–164.
  • Ardiles LG, Valderrama G, Moya P, et al. Incidence and studies on antigenic specificities of antineutrophil-cytoplasmic autoantibodies (ANCA) in poststreptococcal glomerulonephritis. Clin Nephrol. 1997;47:1–5.
  • Abdellatif AA, Waris S, Lakhani A, et al. True vasculitis in lupus nephritis. Clin Nephrol. 2010;74:106–112.
  • Nishino T, Minami K, Uramatsu T, et al. An elderly patient with diabetic nephropathy complicated by ANCA-associated nephritis. Intern Med. 2012;51:1227–1232.
  • Keven K, Akar H, Kutlay S, et al. MPO-ANCA-associated pulmonary-renal vasculitis in a patient with diabetes mellitus. J Nephrol. 2002;15:720–723.
  • Jennette JC, Falk RJ, Bacon PA, et al. 2012 Revised International Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65:1–11.
  • Scaglioni V, Scolnik M, Catoggio LJ, et al. ANCA-associated pauci-immune glomerulonephritis: always pauci-immune? Clin Exp Rheumatol. 2017;35:55–58.
  • Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179–c184.
  • Orth SR, Ritz E. The nephrotic syndrome. N Engl J Med. 1998;338:1202–1211.
  • Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937–2944.
  • Okano K, Yumura W, Nitta K, et al. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis. Clin Nephrol. 2001;55:275–281.
  • Hauer HA, Bajema IM, Van Houwelingen HC, et al. Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int. 2002;62:1732–1742.
  • Yorioka N, Taniguchi Y, Amimoto D, et al. Clinicopathological study of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Clin Nephrol. 1999;52:293–296.
  • Rostoker G, Behar A, Lagrue G. Vascular hyperpermeability in nephrotic edema. Nephron. 2000;85:194–200.
  • Wegener’s Granulomatosis Etanercept T, (WGET) RG. Etanercept plus standard therapy for Wegener’s granulomatosis. N Engl J Med. 2005;352:351–361.